- BRSF announced that Maine Medical Center, a teaching hospital providing health care across Portland, Maine, and northern New England, has placed an order for Pediatric NeuroCap(TM), Company’s pediatric disposable EEG headset.
- EEG testing is increasingly needed in pediatric patients, where neurological workup faces even bigger challenges than in adults.
- BRSF has developed disposable EEG caps for adults and children to meet the needs of the pediatric neuro testing market; partners with medical facilities to expand its unique technology and respond to unmet market need.
Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare technology company developing solutions in the brain diagnostics space, announced today that Maine Medical Center had placed an order for a limited supply of Pediatric NeuroCap(TM), the Company’s pediatric disposable EEG caps. As a 637-licensed-bed teaching hospital for Tufts University School of Medicine, Maine Medical Center provides health care for the people of greater Portland, the entire state of Maine, and northern New England (
https://ibn.fm/3E1LM).
The Pediatric NeuroCap(TM) pre-gelled EEG headset is designed to help medical staff conduct electroencephalogram (“EEG”) testing without some of the usual obstacles found in pediatric patients. Traditional EEG testing can be a cumbersome process requiring steps such as measuring and marking the patient’s head, cleaning the scalp, and conducting required sanitation protocols after the testing. With children and infants, the process can be even more challenging as they often resist testing. Also, clinicians must improvise to make equipment that often comes only in adult size fits children’s smaller head circumference.
The Pediatric NeuroCap(TM) is designed to respond to all these obstacles bringing a cost-effective, easy to use and disposable EEG headset made specifically with children in mind. It fits their head easily features 22 pre-gelled electrodes in compliance with the 10-20 international system. It can be quickly deployed, providing EEG study for up to four hours in length. Finally, as a disposable piece of equipment, pediatric NeuroCap(TM) is designed to offer the highest hygienic standards, essential during the pandemic.
“We are happy to provide our pediatric EEG products to Maine Medical Center. The NeuroCap(TM) for children is designed to address the need for comfort, speed, and reliability within the pediatric population. We hope that Maine Medical Center and other hospitals see the benefits of using the product on an ongoing basis,” stated Brain Scientific’s VP Strategy and Business Development, Amy Griffith.
There is an unmet need for quick and reliable EEG testing in children, who often suffer from various neurological symptoms and conditions, such as epilepsy, seizures, sleep problems, brain infections, and more. According to the American Academy of Pediatrics, around 470,000 children suffer from epilepsy, which makes it one of the most prevalent neurological disorders in children. Epilepsy could lead to dangerous seizures if left undetected. The World Health Organization reports that up to 70% of epilepsy patients could live without seizures if adequately diagnosed and treated. The use of EEG testing in pediatrics could go beyond epilepsy and include diagnosing ADHD, and autism — two conditions often challenging to diagnose, especially in younger pediatric patients (
https://ibn.fm/LkAgx).
Brain Scientific is committed to helping healthcare facilities around the country transform traditionally cumbersome and time-consuming EEG testing into a quick and user-friendly process. After serving the adult brain diagnostics market, the Company was determined to go a step further and make its top-notch technology available for pediatric patients as it was clear that there was a significant unmet market need. Brain Scientific continues to extend the benefits of its unique technology across expanding number of segments of neurological diagnostics markets, and collaboration with Maine Medical Center is a clear step in that direction.
For more information, visit the company’s website at
www.BrainScientific.com/Invest-Now.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the Company’s newsroom at
https://ibn.fm/BRSF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via
InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with
BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit
https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:
http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the
InvestorBrandNetwork.